Gene: NAPEPLD
Official Full Name: N-acyl phosphatidylethanolamine phospholipase Dprovided by HGNC
Gene Summary: NAPEPLD is a phospholipase D type enzyme that catalyzes the release of N-acylethanolamine (NAE) from N-acyl-phosphatidylethanolamine (NAPE) in the second step of the biosynthesis of N-acylethanolamine (Okamoto et al., 2004 [PubMed 14634025]).[supplied by OMIM, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27137 | NAPEPLD Knockout cell line (HeLa) | Human | NAPEPLD | 1:3~1:6 | Negative | Online Inquiry |
KO27138 | NAPEPLD Knockout cell line (HCT 116) | Human | NAPEPLD | 1:2~1:4 | Negative | Online Inquiry |
KO27139 | NAPEPLD Knockout cell line (HEK293) | Human | NAPEPLD | 1:3~1:6 | Negative | Online Inquiry |
KO27140 | NAPEPLD Knockout cell line (A549) | Human | NAPEPLD | 1:3~1:4 | Negative | Online Inquiry |
NAPEPLD Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the functional role of the N-acyl-phosphatidylethanolamine phospholipase D (NAPEPLD) gene. This product utilizes advanced CRISPR-Cas9 technology to effectively silence the expression of the NAPEPLD gene, allowing researchers to investigate its role in various biological processes, including lipid metabolism and neuroinflammation. By providing a system to observe the effects of NAPEPLD gene loss-of-function, these cell lines facilitate a deeper understanding of the pathways in which this enzyme is involved.
The key mechanism of action involves targeted editing, where guide RNA directs the Cas9 nuclease to the specific genomic locus of the NAPEPLD gene, leading to precision knockout. This gene disruption results in the absence of NAPEPLD expression, allowing researchers to observe the consequent phenotypic changes in lipid profiles and cellular signaling pathways. It is crucial for research in fields such as neurobiology and cancer biology, where alterations in lipid signaling significantly affect cellular responses and disease progression.
One of the scientific advantages of using NAPEPLD Gene Knockout Cell Lines is their ability to serve as control models in comparative studies. Unlike traditional pharmacological inhibition methods, which may produce off-target effects or incomplete inhibition, these knockout lines provide a clean genetic background, ensuring that researchers can attribute observed changes directly to the absence of the NAPEPLD gene. Additionally, they are readily applicable to high-throughput screening and can be utilized in assays aimed at drug discovery or biomarker identification.
Researchers and clinicians will find significant value in these cell lines due to their ability to shed light on crucial biological pathways and their implications in disease. By enabling innovative investigations into lipid metabolism disorders and neurodegenerative diseases, these cell lines represent a frontier for advancing scientific knowledge and therapeutic strategies.
Our company, known for its expertise in developing reliable and innovative genetic products, is committed to providing high-quality biological models that enhance researchers’ capacity to uncover the complexities of gene function and its relevance in health and disease. The NAPEPLD Gene Knockout Cell Lines are a testament to our commitment to supporting the scientific community in its quest for discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.